RMD News & Events

Frazier Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, announced it has entered into a definitive agreement to acquire MatrixCare from ResMed. "Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers," said Ryan Lucero, General Partner at Frazier Healthcare Partners. "We are thrilled to partner with the MatrixCare team and plan to invest aggressively in product innovation to help providers deliver better outcomes as the post-acute care landscape continues to evolve," added Clarissa Berman, Principal at Frazier Healthcare Partners. The proposed transaction, which is subject to customary closing conditions, is expected to be completed during the third quarter of 2026.

Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners. The transaction includes MatrixCare and related software offerings historically sold under the MatrixCare brand, including Healthcare First, Citus and home health and hospice solutions. It excludes Resmed's other software businesses, Brightree in the U.S. and Medifox Dan in Germany. The transaction is expected to close during the first quarter of Resmed's fiscal year 2027, subject to required regulatory approvals and customary closing conditions. Until closing, MatrixCare will continue to operate as part of Resmed, with no changes to customer service or support.